Recently we have shown the antiproliferative activity of Gleditsia sinensis fruit extract (GSE) on various solid tumour and leukaemia cell lines as well as primary cultured bone marrow cells isolated from patients with acute and chronic myelogenous leukaemia. We further studied whether the growth inhibitory effect of GSE involves basic fibroblast growth factor (bFGF) in cancer cell lines including breast cancer MDA-MB231, nasopharyngeal cancer CNE-2 and prostate cancer LNCaP. We also investigated whether GSE could alter the production of nitric oxide (NO) pattern from these cancer cell lines. Growth inhibition assay was quantitated by sulforhodamine B protein staining method. Enzyme linked immunosorbent assay (ELISA) was used to quantitate the total bFGF protein. The amount of NO secreted into culture medium in terms of nitrite ion concentration was measured by the Greiss method. ELISA showed that GSE could stimulate total bFGF protein level which was dosedependent. NO production was also stimulated from these cancer cell lines after treating with GSE. Both of the increment in total bFGF and NO levels were correlated with the degree of growth inhibition. Changes involving cell shrinkage and detachment of cancer cells could readily be observed. Taken together, our results here suggest that growth inhibition induced by GSE in these solid tumour cell lines may involve both bFGF and NO regulations.
Introduction
Basic fibroblast growth factor (bFGF) is a common angiogenic inducer and mitogenic factor in the cell system (1) . The bFGF interacts with its specific cell surface receptor and this consequently initiates a series of intracellular signalling events. However, it was reported that bFGF could also process the growth inhibition activity in human breast cancer cells (2) . Nitric oxide (NO) is a free radical gas produced by nitric oxide synthase (NOS) which exists in three enzyme isoforms (3) . It was shown that NO is crucial in many important physiological and pathological processes (4) . Under normal condition, NO regulates vascular tone and platelet aggregation while in pathological condition NO could induce apoptosis or necrosis (5) .
It has been suggested that many herbal plant extracts exert growth inhibitory activity on tumour cells. An extract from the seed of the plant Livistona chinensis was shown to have tumour growth inhibition activity on both MCF-7 breast cancer and HT-29 colon cancer cell lines in a dose dependent manner (6) . It was also reported that 15 out of 71 of traditional herbal Chinese medicines in the forms of extract were able to process >50% growth inhibition on at least 4 out of 5 breast cancer cell lines tested in vitro (7) . Thus it seems that the growth inhibitory ability of certain herbal plant extracts on cancer cells is promising.
Gleditsia sinensis is a traditional Chinese medicine commonly used in mainland China (8) . The G. sinensis fruit extract (GSE) was shown to exhibit cytotoxic activity in vitro on breast cancer (7) and nasopharyngeal carcinoma (9) . We have recently shown that apoptosis is involved in the antiproliferative activity of GSE on both solid tumour (10) and leukaemia cell lines as well as primary cultured leukaemia cells obtained from the bone marrow of patients with acute and chronic myelogenous leukaemia (11) . Here we further investigated whether bFGF would be involved in the growth inhibitory action of GSE on three solid tumour cell lines including breast, nasopharyngeal and prostate.
Furthermore, the possibility of whether GSE could stimulate NO production from these cancer cell lines was also investigated. The significance of these findings will be discussed.
Materials and methods
Preparation of GSE extract. The dried fruit of G. sinensis was grounded into powder in a mortar. Then a known amount of fruit powder was mixed with a known volume of absolute ethanol and warmed with stirring. After all the fruit powder was dissolved completely, a known volume of mixture was dried and the concentration of GSE in the ethanol extract was calculated. This stock GSE ethanol extract was then diluted to at least 1,000-fold during cell culture condition so that ethanol would contribute to less than 0.1% of the final volume. Sulforhodamine B protein staining assay. Briefly, different cancer cells were seeded in a 96-well microtitre plate on the first day. On the second day, growth medium was changed and different concentrations of GSE were added. After either 6 or 24 h, cells were fixed with trichloroacetic acid and then stained with sulforhodamine B. Then cells were washed and stained protein was dissolved in Tris-solution. The corresponding optical absorbance was measured at 540 nm using a microplate reader (Bio-Rad).
Morphological changes of cancer cell. Cancer cells were seeded and then GSE at a concentration of 20 µg/ml was added. Any morphological changes after 6 h were observed under an inverted microscope.
Quantitation of bFGF protein. Different types of cancer cells
were seeded in their corresponding conditioned medium. After 24 h, conditioned medium was changed and different concentration of GSE including 10, 15 and 20 µg/ml were added. After 6 and 24 h, culture medium was collected for bFGF protein quantitation while cell lysate was collected for both bFGF protein quantitation and total cellular protein standardization. The bFGF ELISA kit was purchased from Oncogene science and experiment was performed according to the instruction provided. The optical absorbance was measured at the wavelength of 450 nm and a correction was then made at the wavelength of 540 nm. A standard curve was constructed using the standard bFGF provided. Total cellular protein content was determined by the traditional Bradford test (Bio-Rad). A standard curve was constructed using a bovine serum albumin solution as a standard reference. Results were expressed as pg of bFGF per 0.1 mg of total cellular protein.
Detection of nitric oxide production in terms of nitrite ion quantitation.
We quantitated the amount of nitric oxide production in terms of nitrite ion as nitric oxide produced would be rapidly converted to nitrite ion. Briefly, culture medium was collected after treating the cancer cells with GSE. They were then mixed with Greiss solution which contains N-(1-naphthyl)-ethylenediamine dihydrochloride, phosphoric acid and sulfanilamide and the corresponding absorbance were measured as mentioned before. The concentration of nitrite ion generated was calculated based on the sodium nitrite solution as a standard reference. Results were expressed as micro-molarity of nitrite ion detected. The level of nitrite ion reflected NO synthesis.
Results

Effect of GSE on the viability of MDA-MB231, CNE-2 and LNCaP cell lines.
Recently, we have reported that GSE could exert cytotoxic action on numerous solid tumour cell lines, including the breast cancer MDA-MB231 by MTT tetrazolium colourimetric assay (9) . Here sulforhodamine B protein staining assay showed that the cytotoxic action of GSE is also found in both nasopharyngeal (CNE-2) and prostate cancer (LNCaP) cell lines (Fig. 1) . The growth inhibitory activity of GSE on MDA-MB231 that was determined by sulforhodamine B protein staining assay was similar to that by MTT tetrazolium colourimetric assay we reported before (9) .
Morphological changes of cancer cells after GSE treatment.
Cell shrinkage of MDA-MB231 cancer cells could be observed after treating with 20 µg/ml of GSE (Fig. 2) . Furthermore, cancer cells also began to detach and could not form colonies. This was detected after 6 h of 20 µg/ml of GSE incubation. Similar phenomenon could also be found in CNE-2 and LNCaP cancer cells (results not shown).
Total bFGF measurement by ELISA. The total bFGF level of cancer cell lines after treating with GSE was quantitated by ELISA. There was a general increment of total bFGF from 10 to 15 µg/ml and with a noticeable increment especially at 20 µg/ml of GSE treatment for all the three cell lines tested after 6 and 24 h incubation (Fig. 3) . The bFGF stimulatory effect by GSE was dose-dependent.
Nitric oxide production. We quantitated the amount of NO production by means of measuring the nitrite ion concentration in the culture medium using the Greiss reagent after treating the cancer cells with GSE. We could not detect any nitrite ion present in the three cell lines when they were either untreated or treated with 10 µg/ml of GSE as they might be lower than the lower detection limit. There was in general an increment of nitrite ion concentration with increasing the GSE concentration from 15 to 20 µg/ml in all the three cancer cell lines for both time points tested (Fig. 4) .
Discussion
The bFGF is generally considered to be an inducer for both cell growth and angiogenesis. However, recent research demonstrated that bFGF exerts a growth inhibitory effect on human breast cancer (12) . The bFGF induces both mitogenic and growth arrest inhibitory cell cycle G 1 event, which results in a net inhibitory effect (13) . A similar contradictory phenomenon has also been observed in nasopharyngeal carcinoma (14) . The growth of the nasopharyngeal carcinoma cell line CG-1 and its sublines were also inhibited by bFGF. Interestingly, the autosecreted bFGF also imposed an inhibitory effect on basal cell growth as a subline secreted a low level of bFGF into the growth medium exhibited a higher growth rate and vice versa. In prostate carcinoma, it is also reported that bFGF could down regulate the androgen receptor protein from LNCaP cells in a dose-dependent manner both in the presence or absence of dihydrotestosterone. The downregulation of androgen receptor protein was observed already after 8 h of bFGF treatment and a maximal inhibition was found one day after adding bFGF to the cell culture environment (15). Thus it is highly possible that the activity of bFGF is controversial in certain types of carcinomas. The evidence suggested that any therapeutic candidate that could increase bFGF protein level from cancer cell might impose growth inhibition in these types of carcinoma. Our results here demonstrated that GSE could stimulate the bFGF level and that was correlated with the degree of growth inhibition. It is reported that exposure of MCF-7 breast cancer cells to bFGF also could activate MAPKs ERK1 and ERK2 (2, 13, 16) and this pathway involves Ras/Raf-1 (17) . Recent investigation from Fenig et al showed that Ras may not be involved in the bFGF induced growth inhibition as interfering with the Ras signal transduction pathway by lovastatin did not affect the growth inhibitory action of bFGF in MCF-7 cancer cells (18) . Further work is now being carried out to elucidate whether Ras/Raf-1 would be recruited in the GSE induced growth inhibition.
The role of NO in cell growth and inhibition is also puzzling. Whether it exerts a deleterious or beneficial effect on a cell depends on many factors including concentration, exposure time and the surrounding microenvironment. Low amount (nano-molarity range) is essential for normal regulatory function while high amount (micro-molarity range) as produced by macrophages are necessary for inducing cellular cytotoxicity (19) . It has also been demonstrated that some NO donors are cytotoxic to tumour cells in vitro (20) . Simeone et al showed that N-(4-hydroxyphenyl)retinamide (4-HPR) could inhibit many breast cancer cells (21) . The level of growth inhibition and apoptotic induction by 4-HPR was directly correlated with the amount of NO produced. 4-HPR could increase the expression of both inducible NO synthase (NOSII) and endothelial NOS (NOSIII). Our results also demonstrated that GSE could increase the nitrite ion concentration, which might directly reflect the level of NO produced from the three cancer cell lines tested. As the increment of nitrite ion concentration was correlated with the extent of growth inhibition, we speculate that increased NO level could also contribute to the growth inhibitory activity of GSE on cancer cell lines. Analyzing the changes in those nitric oxide synthase levels could delineate the underlying molecular regulatory mechanism concerned.
We used the sulforhodamine B protein staining assay to study the growth inhibitory activity of GSE on tumour cell lines including MDA-MB231 and the results obtained was similar to that of using MTT tetrazolium colourimetric assay as we previously reported (10). Pagliacci et al showed that genistein, the natural isoflavone, inhibited tumour cell growth in vitro but enhanced mitochondrial reduction of tetrazolium salts (22) . Since genistein arrested cells at G 2 /M of cell cycle and increased mitochondrial number and activity as well as increased the uptake of rhodamine 123, which also increased the MTT tetrazolium reduction to formazan and this could lead to an error for evaluating cell growth and survival in vitro. A similar G 2 /M cell cycle arrest could also be observed in many anti-tumour drugs including vinblastine (23) . In our case, the cell cycle arrest of GSE on cancer cells was most likely not at G 2 /M phase (unpublished data) and a similar growth inhibitory degree of GSE on leukaemia cell lines was found when comparing MTS colourimetric assay (11) with trypan blue exclusion assay (unpublished data). The information further provides experimental evidence to support the use either tetrazolium salt or protein staining method to study the growth inhibitory activity of GSE on cancer cells in vitro.
The findings of this study suggested that GSE induced growth inhibition involved the increment of bFGF. Recently we have shown that GSE could inhibit VEGF secretion from cancer cell lines and primary cultured acute myelogenous leukaemia cells (24) . Actually we believe that antiangiogenic process is very complicated. It depends on the resultant complex counteraction between the angiogenic inducers and inhibitors. By using NO donors, increased NO level was also reported to be anti-angiogenic (3) . In this study, we showed that GSE could induce NO production in cancer cells. We have also shown that GSE could reduce the angiogenic activity of bFGF by using chick chorioallantoic membrane assay (24) . Taking these together, we speculate that in between the dynamic interaction of those angiogenic inducers and inhibitors, there may still be a net resultant force for GSE to exert its anti-angiogenic activity in vivo. Nude mice xenograft experiment is now on-going to clarify this issue.
In East Asia, especially the South-East part of China, nasopharyngeal carcinoma is a common solid tumour with a high incidence. This high incidence may be due to the eating habits of the Chinese. While both breast and prostate cancer mainly affect the Western parts of the world. Thus, identification of any novel therapeutic regimens would be beneficial. Understanding the mechanistic actions and pathways involved is necessary before any clinical usefulness.
